Nashville, Tenn., October 13, 2008 – The attorneys at Harwell Howard Hyne Gabbert & Manner (H³GM) advised OralDNA Labs Inc. and its management team, led by CEO Brian Carr and Chairman Tom Nabors, in the company’s formation and private-equity funding . Private equity firm Oak Investment Partners participated in the funding.  

OralDNA is a specialty diagnostics company established to bring medical laboratory diagnostics to the dental field.   For more information, please visit www.oraldna.com.

H³GM previously represented Mr. Carr in other ventures, most recently American Esoteric Laboratories, including its formation, venture capital funding, growth through strategic acquisitions, and eventual sale to Sonic Healthcare, a public Australian healthcare company, for over $180 million. H³GM partner David Cox said of Mr. Carr, “Brian is a terrific entrepreneur and it has been a pleasure partnering with him during the different stages of his business ventures, particularly his newest company , OralDNA, which I see as a truly innovative life sciences opportunity.”